Younis J S, Matilsky M, Radin O, Ben-Ami M
Reproductive Medicine Unit, Department of Obstetrics and Gynecology, Poriya Medical Center, Tiberias, Israel.
Fertil Steril. 2001 Aug;76(2):294-9. doi: 10.1016/s0015-0282(01)01918-5.
To gain insight into the physiologic as well as the clinical significance of premature luteinization in the long gonadotropin-releasing hormone agonist (GnRH-a) cycles and to evaluate whether it may be a manifestation of low ovarian reserve.
Prospective evaluation.
A university-affiliated reproductive medicine unit.
PATIENT(S): Seventy-six consecutive infertile women.
INTERVENTION(S): The long GnRH-a protocol was used for IVF-ET treatment.
MAIN OUTCOME MEASURE(S): Women in the study were prospectively evaluated in their first cycle of treatment and were divided into those with (study group) or without premature luteinization (control group). Premature luteinization was defined as P/E2 ratio of more than 1 on the day of hCG administration.
RESULTS(S): Thirty-one (41%) of the women in the study demonstrated premature luteinization. Patients' characteristics were comparable between the two groups. Late follicular P/E2 ratio was significantly and considerably higher in the study as compared to the control group, 2.4 +/- 1.7 and 0.7 +/- 0.2, respectively. Ovarian reserve parameters including day 3 FSH, E2 level on hCG day, total amount of hMG, number of follicles, oocytes, and embryos were significantly inferior in the study as compared to the control group. P levels on hCG day were significantly higher in the study as compared to the control group, 1.9 +/- 0.7 ng/mL and 1.2 +/- 0.6 ng/mL, respectively. However, LH levels on hCG day did not differ between the groups, 1.4 +/- 0.7 mIU/mL and 1.2 +/- 0.7 mIU/mL, respectively. The clinical pregnancy rate was significantly lower in the premature luteinization group as opposed to controls, 13% and 42%, respectively.
CONCLUSION(S): Premature luteinization, defined as late follicular P/E2 >1, in long GnRH-a cycles seems to adversely affect clinical outcome. Our findings in this setting support the notion that premature luteinization could be related to low ovarian reserve and that this manifestation is not necessarily an LH-dependent event.
深入了解长效促性腺激素释放激素激动剂(GnRH-a)周期中过早黄素化的生理及临床意义,并评估其是否可能是卵巢储备功能低下的一种表现。
前瞻性评估。
一所大学附属生殖医学单位。
76例连续的不孕女性。
采用长效GnRH-a方案进行体外受精-胚胎移植(IVF-ET)治疗。
对研究中的女性在其第一个治疗周期进行前瞻性评估,并分为有过早黄素化(研究组)或无过早黄素化(对照组)的女性。过早黄素化定义为在注射人绒毛膜促性腺激素(hCG)当天孕酮/雌二醇(P/E2)比值大于1。
研究中的31例(41%)女性出现过早黄素化。两组患者的特征具有可比性。与对照组相比,研究组卵泡晚期的P/E2比值显著且明显更高,分别为2.4±1.7和0.7±0.2。与对照组相比,研究组的卵巢储备参数包括第3天促卵泡生成素(FSH)、hCG日的雌二醇(E2)水平、人绝经期促性腺激素(hMG)总量、卵泡数量、卵母细胞数量和胚胎数量均显著较差。与对照组相比,研究组hCG日的孕酮(P)水平显著更高,分别为1.9±0.7 ng/mL和1.2±0.6 ng/mL。然而,两组hCG日的促黄体生成素(LH)水平无差异,分别为1.4±0.7 mIU/mL和1.2±0.7 mIU/mL。与对照组相比,过早黄素化组的临床妊娠率显著更低,分别为13%和42%。
在长效GnRH-a周期中,定义为卵泡晚期P/E2>1的过早黄素化似乎会对临床结局产生不利影响。我们在这种情况下的研究结果支持过早黄素化可能与卵巢储备功能低下有关的观点,并且这种表现不一定是依赖LH的事件。